Interleukin-18 promoter polymorphisms and risk of ischemic stroke

21Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Ischemic stroke (IS) is a major cause of morbidity and mortality around the world. Interleukin-18 (IL-18) plays an important role in the pathogenesis of IS and IL-18 promoter polymorphisms have been shown to be associated with levels of expression of IL-18. We investigated the association of two functional polymorphisms in IL-18 promoter, -607C/A (rs1946518) and -137G/C (rs187238), with the risk of ischemic stroke in a Han Chinese population of 423 patients and 384 healthy controls matched for sex and age. The results revealed that the -607C allele was associated with an increased risk of IS with an odds ratios (OR) of 1.358 (P = 0.002, power = 100%) and the presence of the -137G allele was correlated with increased the risk of IS in the subtype of patients with large artery atherosclerosis (LAA) (OR = 1.583, P = 0.02, power = 94%). Patients with the -607C/-137G haplotype also had significantly increased risk of IS compared to controls (OR = 1.341, P = 0.005, power = 100%). Our findings suggest that these functional polymorphisms in the IL-18 promoter are involved in development of IS in the Han Chinese population. © 2010 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Zhang, N., Yu, J. T., Yu, N. N., Lu, R. C., Ma, T., Wang, N. D., … Tan, L. (2010). Interleukin-18 promoter polymorphisms and risk of ischemic stroke. Brain Research Bulletin, 81(6), 590–594. https://doi.org/10.1016/j.brainresbull.2010.01.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free